Turnstone Biologics CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OrbiMed Advisors and OrbiMed Capital GP VI LLC disposed of their entire 3,099,265 shares of Turnstone Biologics common stock following a cash tender offer by XOMA Royalty Corporation.
Versant Ventures V, LLC and its affiliated entities have fully disposed of their common stock holdings in Turnstone Biologics Corp. following a tender offer.
Turnstone Biologics Director Jerel Davis reports the disposition of common stock holdings through various Versant entities as part of a cash tender offer by XOMA Royalty Corporation.
Turnstone Biologics Director Rishi Gupta disposed of over 3 million shares of common stock as part of a cash tender offer by XOMA Royalty Corporation.
Director Kanya Rajangam acquired 12,770 stock options in Turnstone Biologics Corp. on June 3, 2024.
Director Robert J. Gould acquired 12,770 stock options in Turnstone Biologics Corp. on June 3, 2024.
Director Rishi Gupta of Turnstone Biologics Corp. acquired stock options for 12,770 shares at an exercise price of $2.69 on June 3, 2024.
Director Jerel Davis of Turnstone Biologics Corp. acquired stock options exercisable for 12,770 shares of common stock on June 3, 2024.
William D. Waddill, a director of Turnstone Biologics Corp., acquired stock options exercisable for 12,770 shares of common stock on June 3, 2024.
William D. Waddill, a director of Turnstone Biologics Corp., acquired stock options for 25,540 shares on April 15, 2024.